84 related articles for article (PubMed ID: 9079799)
1. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments.
Morkowski S; Raposo G; Kleijimeer M; Geuze HJ; Rudensky AY
Eur J Immunol; 1997 Mar; 27(3):609-17. PubMed ID: 9079799
[TBL] [Abstract][Full Text] [Related]
2. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
3. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
4. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
5. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
Ramachandra L; Song R; Harding CV
J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
[TBL] [Abstract][Full Text] [Related]
6. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
7. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
8. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
9. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
10. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases.
Lem L; Riethof DA; Scidmore-Carlson M; Griffiths GM; Hackstadt T; Brodsky FM
J Immunol; 1999 Jan; 162(1):523-32. PubMed ID: 9886429
[TBL] [Abstract][Full Text] [Related]
11. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes.
Amigorena S; Drake JR; Webster P; Mellman I
Nature; 1994 May; 369(6476):113-20. PubMed ID: 8177316
[TBL] [Abstract][Full Text] [Related]
12. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
13. Assembly of major histocompatibility complex class II subunits with invariant chain.
Neumann J; Koch N
FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
[TBL] [Abstract][Full Text] [Related]
14. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments.
Peters PJ; Neefjes JJ; Oorschot V; Ploegh HL; Geuze HJ
Nature; 1991 Feb; 349(6311):669-76. PubMed ID: 1847504
[TBL] [Abstract][Full Text] [Related]
15. The intracellular transport of MHC class II molecules in the absence of HLA-DM.
Green JM; DeMars R; Xu X; Pierce SK
J Immunol; 1995 Oct; 155(8):3759-68. PubMed ID: 7561080
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody detection of a major self peptide. MHC class II complex.
Murphy DB; Rath S; Pizzo E; Rudensky AY; George A; Larson JK; Janeway CA
J Immunol; 1992 Jun; 148(11):3483-91. PubMed ID: 1375245
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.
Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR
J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114
[TBL] [Abstract][Full Text] [Related]
18. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
Roche PA; Marks MS; Cresswell P
Nature; 1991 Dec; 354(6352):392-4. PubMed ID: 1956401
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
20. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
